IL22 and breast cancer: As shown in Figures 3 and 4, cell proliferation, colony formation, cell cycle entry, apoptosis inhibition, cell motility, migration and invasion abilities were significantly elevated in BC cells treated with IL-22 compared with the control cells treated with PBS.